Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$172,357
New position
Shares Held
18,297
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gem Investment Advisors, LLC holds $16,930,567 across 6 Biotechnology names. FTRE ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABSI |
Absci Corp
|
2,170,863 | $6,512,589 | |
| 2 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,640,069 | $5,576,234 | |
| 3 | LRMR |
Larimar Therapeutics, Inc.
|
854,230 | $3,844,035 | |
| 4 | DRTS |
Alpha Tau Medical Ltd.
|
113,736 | $804,113 | |
| 5 | FTRE |
Fortrea Holdings Inc.
This page
|
18,297 | $172,357 | |
| 6 | ENTX |
Entera Bio Ltd.
|
19,135 | $21,239 |
All Filings in FTRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,357 | 18,297 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||